MedElevator Войти в исследования
← Поиск публикаций

DOI 10.3389/fendo.2022.1057056

Медицинская библиотека · Frontiers in endocrinology · 2022

Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters.

Zmyslowska Agnieszka, Smyczynska Urszula, Stanczak Marcin, Jeziorny Krzysztof, Szadkowska Agnieszka, Fendler Wojciech, Borowiec Maciej

СтатьяПоддержка исследования: вне правительства СШАПеревод в очереди

Аннотация

BACKGROUND

Patients with the rare syndromic forms of monogenic diabetes: Alström syndrome (ALMS) and Bardet-Biedl syndrome (BBS) have multiple metabolic abnormalities, including early-onset obesity, insulin resistance, lipid disorders and type 2 diabetes mellitus. The aim of this study was to determine if the expression of circulating miRNAs in patients with ALMS and BBS differs from that in healthy and obese individuals and determine if miRNA levels correlate with metabolic tests, BMI-SDS and patient age.

METHODS

We quantified miRNA expression (Qiagen, Germany) in four groups of patients: with ALMS (n=13), with BBS (n=7), patients with obesity (n=19) and controls (n=23). Clinical parameters including lipids profile, serum creatinine, cystatin C, fasting glucose, insulin and C-peptide levels, HbA1c values and insulin resistance (HOMA-IR) were assessed in patients with ALMS and BBS.

RESULTS

We observed multiple up- or downregulated miRNAs in both ALMS and BBS patients compared to obese patients and controls, but only 1 miRNA (miR-301a-3p) differed significantly and in the same direction in ALMS and BBS relative to the other groups. Similarly, 1 miRNA (miR-92b-3p) was dysregulated in the opposite directions in ALMS and BBS patients, but diverged from 2 other groups. We found eight miRNAs (miR-30a-5p, miR-92b-3p, miR-99a-5p, miR-122-5p, miR-192-5p, miR-193a-5p, miR-199a-3p and miR-205-5p) that significantly correlated with at least of the analyzed clinical variables representing an association with the course of the diseases.

CONCLUSIONS

Our results show for the first time that serum miRNAs can be used as available indicators of disease course in patients with ALMS and BBS syndromes.

Для цитирования: Zmyslowska Agnieszka, Smyczynska Urszula, Stanczak Marcin, Jeziorny Krzysztof, Szadkowska Agnieszka, Fendler Wojciech, Borowiec Maciej. Association of circulating miRNAS in patients with Alstrőm and Bardet-Biedl syndromes with clinical course parameters.. Frontiers in endocrinology. 2022. DOI: 10.3389/fendo.2022.1057056.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.